Local immunotherapy by the synergism of monobenzone and imiquimod cream (MI) for cutanous metastases in stage III-IV melanoma patients.
Phase of Trial: Phase II
Latest Information Update: 25 Jun 2011
At a glance
- Drugs Imiquimod (Primary) ; Monobenzone (Primary)
- Indications Cancer metastases; Malignant melanoma
- Focus Therapeutic Use
- 25 Jun 2011 New trial record